Navigation Links
IGY Immune Technology & Life Sciences Purchases Manufacturing Facility to Produce Purified Immunoglobulin Y (IgY)

THUNDER BAY, Ontario, April 30, 2012 /PRNewswire/ -- IGY Immune Technology & Life Sciences has acquired manufacturing capabilities to produce its proprietary IgY products.  IgY from chicken egg yolks has long been recognized among scientists for its immune enhancing benefits in humans as well as its ability to deliver customized antibodies to fight sickness and maintain good health.  Until now, a consistent, purified source has not been available commercially.  IGY Immune Technology & Life Sciences expects to be producing IgY by the end of 2012.

"The acquisition of this facility and our existing intellectual property position make IGY Immune Technology the world's leader in the production of IgY," said Terry Dyck, chief executive officer. "The production of IgY at higher purity levels and lower cost will create a number of product development opportunities across the nutrition, cosmetic, pharmaceutical and animal health industries."

The existing world supply of IgY is very limited and expensive.  IGY Immune Technology's unique process is able to produce commercial quantities of IgY from chicken egg yolk.  The manufacturing facility is in close proximity to major egg producers and the production process utilizes no toxic chemicals allowing the egg yolk to be returned back into the food supply.

IGY Immune Technology & Life Sciences is already in the commercialization process with its first product and has a number of business partnerships in development with major life sciences corporations.  An opportunity for investment in IGY Immune Technology is also available.

"We're establishing ourselves already with leading companies that have been following IgY developments," said Dyck.  "We're moving forward in securing these partnerships as well as providing a profitable opportunity for investors."

For more information about IGY Immune Technology & Life Sciences, visit its web site at:

SOURCE IGY Immune Technology & Life Sciences
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Discovery in Nature elucidates immune cells in skin and supports novel vaccine approach
2. Argos Therapeutic Arcelis™ Immunotherapy AGS-003 in Combination With Sunitinib Shows Statistically Significant Correlation of Immune System Response to Overall Survival in Phase 2 Study in Patients with Advanced Renal Cell Carcinoma (RCC)
3. MU researchers identify key plant immune response in fight against bacteria
4. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
5. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
6. Immune Design Corp. and Sanofi-Aventis Announce Research Collaboration
7. Immune Design Corp. Appoints Guy F. Cipriani as Chief Business Officer
8. Alcohol-related behavior changes -- blame your immune system
9. Immune Deficiency Foundation Launches Free Accredited Course for Nurses About Primary Immunodeficiency and Immunoglobulin Therapy
10. New HIV vaccine approach targets desirable immune cells
11. David H. Murdock Research Institute Assumes Control of the Immune Tolerance Institute and Establishes a State of the Art Human Immune Monitoring Laboratory for Biomarker Discovery and Development
Post Your Comments:
(Date:11/25/2015)... 2015 Studies reveal the differences ... and pave the way for more effective treatment for one ...   --> --> ... problems in cats, yet relatively little was understood about the ... have been conducted by researchers from the WALTHAM Centre for ...
(Date:11/25/2015)... Nov. 25, 2015 Orexigen® Therapeutics, Inc. (Nasdaq: ... in a fireside chat discussion at the Piper Jaffray ... . The discussion is scheduled for Wednesday, December ... .  A replay will be available for 14 ... , Julie NormartVP, Corporate Communications and Business Development ...
(Date:11/24/2015)... Calif. , Nov. 24, 2015 Cepheid ... will be speaking at the following conference, and invited ... New York, NY      Tuesday, December 1, 2015 ... New York, NY      Tuesday, December 1, 2015 ... Jaffray Healthcare Conference, New York, NY ...
(Date:11/24/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) ... of the Toronto Stock Exchange, confirms that as of ... corporate developments that would cause the recent movements in ... --> About Aeterna Zentaris Inc. ... Aeterna Zentaris is a specialty biopharmaceutical company engaged ...
Breaking Biology Technology:
(Date:11/20/2015)... 20, 2015 NXTD ) ("NXT-ID" ... the growing mobile commerce market and creator of the ... , was recently interviewed on The RedChip Money ... this weekend on Bloomberg Europe , Bloomberg Asia, ... --> NXTD ) ("NXT-ID" or the "Company"), a ...
(Date:11/18/2015)... new scientific discoveries deepen our understanding of how cancer ... challenges in better using that knowledge to guide treatment ... children continue to survive pediatric cancer, that counseling may ... John M. Maris, M.D ., a pediatric oncologist ... --> John M. Maris, M.D ., ...
(Date:11/17/2015)... -- Paris , qui s,est ... Paris , qui s,est tenu du 17 ... de l,innovation biométrique, a inventé le premier scanner couplé, ... la même surface de balayage. Jusqu,ici, deux scanners étaient ... empreintes digitales. Désormais, un seul scanner est en mesure ...
Breaking Biology News(10 mins):